According to the brand introduction, Mengniu Future Star's new product is the first HMOs children's liquid formula in China, which specially adds HMOs (breast milk oligosaccharides). Through this, we hope to seize the market opportunity in the new field of HMOs children's liquid formula and become the first product.

On October 7th, the National Health Commission announced that 2 'FL (2' - fucosylactose) and LNnT (lactose-N-neotetraose) in HMOs have been officially approved as food nutritional enhancers, which can be used in infant formula milk powder, formulated milk powder (for children), and special medical baby food.

Among them, Hongmo Biotechnology became the first batch of approved HMOs in China.

According to the scientific consensus on breast milk oligosaccharides (HMOs), HMOs are the third largest solid component in breast milk and are of great significance in meeting the nutritional needs of infants and young children. Research has shown that HMOs can help regulate the proportion of bifidobacteria in the intestines of infants and young children, reduce the probability of lower respiratory tract infections and otitis media, and reduce the use of fever reducing and antibiotic drugs [1].